Canonical enzyme expression. mRNA expression relative to sham (A, E), protein abundance by LC-MS/MS (B, F), western blot expression (C, G) and quantification of western blots (D, H... by Dawn B. Lammert (21175128)

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…Oral leukoplakia (OL), an oral potentially malignant disorder begins with a hyperplastic/hyperkeratotic stage at which no genome-scale somatic single nucleotide variant profiles have been described so far. …”

Fluorescence detection of cellular toxicity as a function of starvation or treatment with the mTOR inhibitor, XL-765. by Kara R. Vogel (739629)

Table 1_United States military working dogs from 2019 to 2021: analysis of causes of service discharge and decreased service life.docx by Dakota Discepolo (16804191)

“…ANOVA analysis comparing mean service life resulted in significant differences of mean overall service with main effects of breed (p = 0.0252), outcome (p = 0.0004), service discharge category (p < 0.0001), and subpopulation (p < 0.0001).…”

The <i>Listeria</i> Small RNA Rli27 Regulates a Cell Wall Protein inside Eukaryotic Cells by Targeting a Long 5′-UTR Variant by Juan J. Quereda (651911)

“…The 234-nucleotide 5′-UTR is also the target of a small RNA (sRNA) denoted Rli27, which we identified by bioinformatics analysis as having extensive base pairing potential with the long 5′-UTR. …”

A BMP7 Variant Inhibits Tumor Angiogenesis <i>In Vitro</i> and <i>In Vivo</i> through Direct Modulation of Endothelial Cell Biology by Courtney M. Tate (555115)

“…Importantly, in an <i>in vivo</i> angiogenic plug assay that serves as a measurement of angiogenesis, BMP7v significantly decreased hemoglobin content indicating inhibition of neoangiogenesis. …”

Data_Sheet_1_miR482f and miR482c-5p from edible plant-derived foods inhibit the expression of pro-inflammatory genes in human THP-1 macrophages.docx by Ester Díez-Sainz (17485836)

“…Transfections with miR482f and miR482c-5p mimics decreased the gene expression of CLEC7A and NFAM1, and TRL6, respectively, in human THP-1 monocytes differentiated to macrophages, which had an impact on gene expression profile of inflammatory biomarkers. …”

Limiting Sox2 in endothelium decreases EndMTs and calcification in <i>Ins2</i>^{<i>Akita/+</i>} aortas. by Pierre J. Guihard (3391721)

“…<p>(a-b) Decreased expression of Sox2, stem cell and mesenchymal markers in aortas of <i>Cdh5</i>^<i>Cre</i><i>Sox2</i>^{<i>Flox/wt</i>}<i>Ins2</i>^{<i>Akita/+</i>}, as shown by real-time PCR (a) and immunoblotting (b). …”

MBL decreases <i>C. albicans</i>-stimulated NF-κB binding activity and translocation in PMA-activated THP-1 cells. by Mingyong Wang (504578)

Over-expression of YKL-40 in 76N MECs decreases E-cad and β-casein, but increases MMP-9 expression and cell invasiveness. by Steve Scully (202724)

Increased retention of chemotherapeutics in MDR cells treated for extended times with P-glycoprotein inhibitor decreases cell motility as determined by wound healing assays. by Amila K. Nanayakkara (6812384)

Early mobilization of critically ill patients in the intensive care unit: A systematic review and meta-analysis by Lan Zhang (90951)

“…Early mobilization decreased the incidence of ICU-acquired weakness (ICU-AW) at hospital discharge (three studies, 190 patients, relative risk (RR): 0.60, 95% confidence interval (CI) [0.40, 0.90]; <i>p</i> = 0.013, <i>I</i>^<i>2</i> = 0.0%), increased the number of patients who were able to stand (one study, 50 patients, 90% vs. 62%, <i>p</i> = 0.02), increased the number of ventilator-free days (six studies, 745 patients, standardized mean difference (SMD): 0.17, 95% CI [0.02, 0.31]; <i>p</i> = 0.023, <i>I</i>^<i>2</i> = 35.5%) during hospitalization, increased the distance the patient was able to walk unassisted (one study, 104 patients, 33.4 (0–91.4) meters vs. 0 (0–30.4) meters, <i>p</i> = 0.004) at hospital discharge, and increased the discharged-to-home rate (seven studies, 793 patients, RR: 1.16, 95% CI [1.00, 1.34]; <i>p</i> = 0.046). …”

Data_Sheet_1_Effectiveness of a program to lower unwanted media screens among 2–5-year-old children: a randomized controlled trial.docx by Nimran Kaur (11008865)

“…In the post-intervention assessment, 161 and 166 families continued while, at the follow-up assessment, 154 and 147 were in the intervention and control arm, respectively. The mean difference in ST on a typical day [27.7 min, 95% Confidence Interval (CI) 5.1, 50.3] at the post-intervention assessment significantly (p < 0.05) decreased in the intervention (102.6 ± 98.5 min) arm as compared with the control (130.3 ± 112.8 min) arm. …”

Data_Sheet_1_Effectiveness of a program to lower unwanted media screens among 2–5-year-old children: a randomized controlled trial.docx by Nimran Kaur (11008865)

“…In the post-intervention assessment, 161 and 166 families continued while, at the follow-up assessment, 154 and 147 were in the intervention and control arm, respectively. The mean difference in ST on a typical day [27.7 min, 95% Confidence Interval (CI) 5.1, 50.3] at the post-intervention assessment significantly (p < 0.05) decreased in the intervention (102.6 ± 98.5 min) arm as compared with the control (130.3 ± 112.8 min) arm. …”